AML (ACUTE MYELOGENOUS LEUKEMIA)

Clinical trials for AML (ACUTE MYELOGENOUS LEUKEMIA) explained in plain language.

Never miss a new study

Get alerted when new AML (ACUTE MYELOGENOUS LEUKEMIA) trials appear

Sign up with your email to follow new studies for AML (ACUTE MYELOGENOUS LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet finished but already full! 1 Completed 1

Cancer patients monitored for years after revolutionary cell therapy

Disease control ENROLLING_BY_INVITATION

This study follows patients who previously received AvenCell's CAR-T cell therapy in earlier clinical trials. Researchers want to understand the long-term safety and effectiveness of these cancer treatments over time. The study will track 178 patients with various blood cancers a…

Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)

Sponsor: AvenCell Therapeutics, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

AML (ACUTE MYELOGENOUS LEUKEMIA)

Get alerted when new AML (ACUTE MYELOGENOUS LEUKEMIA) trials appear

Cancer patients monitored for years after revolutionary cell therapy